UK markets close in 5 hours 45 minutes

Renalytix Plc (RNLX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.6911+0.0013 (+0.19%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-42,246
-45,607
-45,276
-31,010
-9,844
Depreciation & amortisation
554
508
489
2,096
70
Stock-based compensation
2,313
2,932
4,621
2,180
1,159
Change in working capital
2,145
5,749
-192
3,615
-629
Inventory
-
-
-807
-27
-326
Other working capital
-36,152
-34,085
-46,586
-26,262
-10,753
Other non-cash items
-
51
-119
-495
-
Net cash provided by operating activities
-36,152
-34,085
-45,924
-24,632
-9,522
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-662
-1,630
-1,231
Acquisitions, net
-
-
0
-62
0
Purchases of investments
-
-
0
0
-21,260
Sales/maturities of investments
-
-
0
1,000
21,400
Other investing activities
-
-
-
-96
-83
Net cash used for investing activities
64
0
-662
-741
-1,174
Cash flows from financing activities
Debt repayment
-3,192
-3,180
0
-
0
Common stock issued
20,534
20,557
9,210
77,239
17,276
Other financing activities
-
-
-
-
172
Net cash used provided by (used for) financing activities
-
-
-
-
16,850
Net change in cash
-18,693
-16,651
-23,795
51,866
5,092
Cash at beginning of period
23,816
41,333
65,128
13,293
8,201
Cash at end of period
4,075
24,682
41,333
65,159
13,293
Free cash flow
Operating cash flow
-36,152
-34,085
-45,924
-24,632
-9,522
Capital expenditure
-
-
-662
-1,630
-1,231
Free cash flow
-36,152
-34,085
-46,586
-26,262
-10,753